EUVIMEDObjevte EUVIMED
BeobachtungsstudieMultizentrische StudieKohortenstudieOpen access · CC BY-NC 3.0

Real-World Effectiveness of Single-Inhaler Triple Treatment Through Assorted Respiratory Outcomes When Switched From Multiple-Inhaler Triple Therapies (RESTART): A Prospective Cohort Study of Korean Patients With COPD

Hana Lim iD, Dong Han Kim iD, Song Hee Hong iD, Juyoung Shin iD, Hyesung Lee, Kyeongcheol Shin iD, Seung Won Ra iD, Seung Jun Lee iD

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s499686 ↗

At a glance

Beobachtungsstudie in International Journal of Chronic Obstructive Pulmonary Disease, 2025. Written by Hana Lim and 7 co-authors. Institution: Department of Bio Health Regulatory Science, Sungkyunkwan University, Suwon, Korea. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Nebulizers and Vaporizers, Benzyl Alcohols. Cited 4 times so far (Crossref). The full text is freely available (open access, CC BY-NC 3.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterized by persistent airflow limitation, leading to significant morbidity and mortality. Despite the effectiveness of multiple inhaler triple therapy (MITT), its complexity often results in poor adherence and suboptimal outcomes. Transitioning to single inhaler triple therapy (SITT) may enhance adherence, leading to improved clinical outcomes and quality of life of patients. The Real-World Effectiveness of Single Inhaler Triple Treatment through Assorted Respiratory Outcomes when Switched from Multiple Inhaler Triple Therapies (RESTART) study aimed to evaluate the clinical benefits of switching from MITT to SITT using fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) in a real-world Korean setting. Patients and Methods: This prospective, multicenter, observational study enrolled 107 patients, aged 40 and older, with diagnosed COPD, all previously on MITT. The patients were transitioned to once-daily FF/UMEC/VI administered via the ELLIPTA inhaler. The primary outcome was a change in the COPD Assessment Test (CAT) score after 24 weeks. The secondary outcomes included changes in lung function, exacerbation rates, Modified Medical Research Council Dyspnea Scale scores, and Treatment Satisfaction-Visual Analysis Scale (TS-VAS) scores.

Results

A total of 91 patients completed the 24-week observation. CAT scores significantly improved (mean change = 1.40 points, P = 0.007). Lung function also improved, with a mean increase in the FEV1/FVC ratio (mean change = 4.31%, P = 0.005). Exacerbation rates decreased significantly (incidence rate ratio = 0.45, P = 0.016). Treatment satisfaction increased, with a mean TS-VAS score rise of 1.71 points (P < 0.001).

Conclusion

The transition from MITT to SITT significantly improved COPD symptom management, pulmonary function, exacerbation rate, and treatment satisfaction in Korean cohort. Using a single inhaler to simplify therapy might increase patient compliance and improve clinical outcomes of COPD management.

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveBronchodilator AgentsNebulizers and VaporizersBenzyl AlcoholsChlorobenzenesLungAdrenergic beta-2 Receptor AgonistsQuinuclidinesMuscarinic AntagonistsDrug SubstitutionHumansMaleProspective StudiesFemaleMiddle AgedTreatment OutcomeAgedAdministration, InhalationDrug CombinationsRepublic of KoreaTime FactorsRecovery of FunctionForced Expiratory VolumeAdultQuality of LifeVital CapacityAndrostadienes

Author keywords

adherencechronic obstructive pulmonary diseasechronic obstructive pulmonary disease assessment test scorereal-world evidencesingle-inhaler triple treatment

Substances

Drug CombinationsBronchodilator AgentsvilanterolBenzyl AlcoholsChlorobenzenesGSK573719Adrenergic beta-2 Receptor Agonistsfluticasone furoateQuinuclidinesMuscarinic Antagonists

Authors and institutions

  • Department of Bio Health Regulatory Science, Sungkyunkwan University, Suwon, Korea.
  • Department of Social Pharmacy, Seoul National University, Seoul, Korea.
  • Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, Korea.
  • Division of Pulmonology and Allergy, Regional Center for Respiratory Disease, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
  • Division of Pulmonology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Basic-Clinical Convergence Research Institute, University of Ulsan, Ulsan, Korea.

ORCID profiles: Hana Lim, Dong Han Kim, Song Hee Hong, Juyoung Shin, Kyeongcheol Shin, Seung Won Ra, Seung Jun Lee

Cite

APA

Lim, H., Kim, D. H., Hong, S. H., Shin, J., Lee, H., Shin, K., Ra, S. W., & Lee, S. J. (2025). Real-World Effectiveness of Single-Inhaler Triple Treatment Through Assorted Respiratory Outcomes When Switched From Multiple-Inhaler Triple Therapies (RESTART): A Prospective Cohort Study of Korean Patients With COPD. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s499686

Vancouver

Lim H, Kim DH, Hong SH, Shin J, Lee H, Shin K, et al. Real-World Effectiveness of Single-Inhaler Triple Treatment Through Assorted Respiratory Outcomes When Switched From Multiple-Inhaler Triple Therapies (RESTART): A Prospective Cohort Study of Korean Patients With COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s499686

BibTeX
@article{Lim2025,
  author = {Lim, Hana and Kim, Dong Han and Hong, Song Hee and Shin, Juyoung and Lee, Hyesung and Shin, Kyeongcheol and Ra, Seung Won and Lee, Seung Jun},
  title = {Real-World Effectiveness of Single-Inhaler Triple Treatment Through Assorted Respiratory Outcomes When Switched From Multiple-Inhaler Triple Therapies (RESTART): A Prospective Cohort Study of Korean Patients With COPD},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s499686}
}
Start for free →